Precigen Inc (NAS:PGEN)
$ 1.695 -0.055 (-3.14%) Market Cap: 426.59 Mil Enterprise Value: 403.68 Mil PE Ratio: 0 PB Ratio: 4.33 GF Score: 45/100

Intrexon Corp at Bank of America Merrill Lynch Health Care Conference Transcript

May 15, 2019 / 10:40PM GMT
Release Date Price: $4.73 (+6.29%)
Michael Leonidovich Ryskin
BofA Merrill Lynch, Research Division - Associate

My name is Mike Ryskin. I'm on the Life Science Tools and Diagnostics team here at Bank of America Merrill Lynch. I'm here on behalf of the Senior Analyst, Derek De Bruin. Unfortunately, he couldn't make it here today, but the show must go on.

So for our next session, we're going to have a short presentation from Intrexon. Joining us today is Randal Kirk, Chairman and CEO. And then towards the end we'll have a brief Q&A session. So Randal, thank you for joining us.

Randal J. Kirk
Intrexon Corporation - Chairman & CEO

So thank you all for coming. I'm going to be making some statements that may contain some risks and uncertainties, that kind of thing. Read this.

I'm going to, in the interest of time, I'm going to do the last slide first. I want to make sure that we get to -- All right. So is this the last slide? I see. Good.

All right. So what I'd really like you to know for sure, and this is the reason I wanted to go to this slide first, is that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot